Medicare Part D coverage · monomethyl fumarate · RxCUI 2393593
monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]
Per the CMS 2026 Part D formulary file, monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] is covered by 2,152 Medicare Part D plans (42.6% of enrollable products), averaging Tier 4.2, with prior authorization required on 95.2% of covering formularies.
- 42.6%
- Plan coverage
- 2,152
- Plans covering
- T4.2
- Avg tier
- 95.2%
- Prior auth required
What the CMS Formulary Data Shows for monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]
Per the CMS 2026 Part D formulary file, monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] (RxNorm concept RXCUI 2393593, generic name monomethyl fumarate) appears on 84 distinct formulary files spanning 2,152 Medicare Part D plan offerings - 42.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.2.
Real-world access to monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] depends on utilization management as much as tier placement: 95.2% of covering formularies require prior authorization. 4.8% require step therapy. 95.2% apply quantity limits.
Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 126 Part D beneficiaries filled monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] in 2023, with total plan-and-beneficiary spending of $4,951,676 and an average per-beneficiary annual cost of $39,299.02. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] today.
Coverage Details
- Formularies covering
- 84
- Plans covering
- 2,152
- Coverage rate
- 42.6%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 95.2% of formularies
- Step therapy required
- 4.8% of formularies
- Quantity limits
- 95.2% of formularies
2023 Medicare Spending
- Beneficiaries
- 126
- Total spending
- $4,951,676
- Avg per beneficiary
- $39,299.02
Tier Distribution Across Plans
Standalone Drug Plans (PDP) Covering monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]
2 standalone prescription drug plans include this drug.
| Plan | Insurer | Tier | PA | ST | Premium | States |
|---|---|---|---|---|---|---|
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | Yes | $0 | - |
| AARP Medicare Rx Preferred from UHC (PDP) | Unitedhealthcare INS. Co. & UHC INS. Co. OF NY | T5 | No | Yes | $0 | - |
Medicare Advantage Plans (MA-PD) Covering monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]
98 Medicare Advantage plans with Part D drug coverage include this drug.
| Plan | Insurer | Tier | PA | Premium | States |
|---|---|---|---|---|---|
| Florida Complete Care-Duals VIP (HMO-POS D-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $0 | FL |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Mercy Care Advantage (HMO D-SNP) | Mercy Care | T1 | Yes | $0 | AZ |
| Elderplan Plus Long-Term Care (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $0 | NY |
| Health Choice Pathway (HMO D-SNP) | Health Choice Arizona, Inc. | T1 | Yes | $0 | AZ |
| Healthfirst CompleteCare (HMO D-SNP) | Healthfirst Health Plan, Inc. | T1 | Yes | $0 | NY |
| IMCare Classic (HMO D-SNP) | Itasca Medical Care | T1 | Yes | $0 | MN |
| Johns Hopkins Advantage MD D-SNP (HMO D-SNP) | Hopkins Health Advantage, Inc. | T1 | Yes | $0 | MD |
| MetroPlus UltraCare (HMO D-SNP) | Metroplus Health Plan, Inc. | T1 | Yes | $0 | NY |
| Senior Whole Health SCO (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Senior Whole Health SCO NHC (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| Molina One Care (HMO D-SNP) | Senior Whole Health, LLC | T1 | Yes | $0 | MA |
| SeniorCare Complete (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| AbilityCare (HMO D-SNP) | South Country Health Alliance | T1 | Yes | $0 | MN |
| Alameda Alliance Wellness (HMO D-SNP) | Alameda Alliance FOR Health | T1 | Yes | $0 | CA |
| CCA One Care (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| CCA Senior Care Options (HMO D-SNP) | Commonwealth Care Alliance, Inc. | T1 | Yes | $0 | MA |
| Mass General Brigham SCO (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
| Mass General Brigham One Care (HMO D-SNP) | Mass General Brigham Health Plan, Inc | T1 | Yes | $0 | MA |
Show the next 30 plans
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Wholecare Medicare Assured Diamond (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $0 | PA |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Health Options West Virginia Inc. | T1 | Yes | $0 | WV |
| Highmark Health Options Duals (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $0 | DE |
| Florida Complete Care (HMO I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Florida Complete Care- In The Community (HMO-POS I-SNP) | Hpmp OF Florida, Inc. | T1 | Yes | $4.80 | FL |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $13.10 | PA |
| Highmark Wholecare Medicare Assured Ruby (HMO D-SNP) | Gateway Health Plan, Inc. | T1 | Yes | $17.60 | PA |
| Elderplan For Medicaid Beneficiaries (HMO-POS D-SNP) | Elderplan, Inc. | T1 | Yes | $22.70 | NY |
| VIVA Medicare Extra Value (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| VIVA Medicare Extra Care (HMO D-SNP) | Viva Health, Inc. | T1 | Yes | $27.70 | AL |
| Highmark Health Options Duals Select (HMO D-SNP) | Highmark Bcbsd, Inc. | T1 | Yes | $31.20 | DE |
| Elderplan Advantage For Nursing Home Residents (HMO-POS I-SNP) | Elderplan, Inc. | T1 | Yes | $44.80 | NY |
| MetroPlus Platinum Plan (HMO) | Metroplus Health Plan, Inc. | T1 | Yes | $58.80 | NY |
| UHC Dual Complete IA-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | IA |
| UHC Dual Complete MO-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | MO |
| UHC Dual Complete NE-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | NE |
| UHC Dual Complete KS-S001 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | KS |
| UHC Dual Complete MO-S3 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | MO |
| UHC Dual Complete KS-Q1 (HMO-POS D-SNP) | Unitedhealthcare OF Wisconsin, Inc. | T5 | No | $0 | KS |
| UHC Dual Complete TN-S001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | No | $0 | TN |
| UHC Dual Complete TN-Y001 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | No | $0 | TN |
| UHC Dual Complete TN-Y2 (HMO-POS D-SNP) | Unitedhealthcare Plan OF THE River Valley, Inc. | T5 | No | $0 | TN |
| AARP Medicare Advantage from UHC MI-0001 (PPO) | Unitedhealthcare Insurance Company | T5 | No | $0 | MI |
| UHC Dual Complete NM-Y1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | No | $0 | NM |
| UHC Dual Complete NM-S1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | No | $0 | NM |
| UHC Dual Complete NM-V1 (PPO D-SNP) | Unitedhealthcare Insurance Company | T5 | No | $0 | NM |
| UHC Dual Complete AZ-S001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T5 | No | $0 | AZ |
| UHC Dual Complete AZ-Y001 (HMO-POS D-SNP) | Arizona Physicians IPA, Inc. | T5 | No | $0 | AZ |
| UHC Dual Complete VA-Y4 (PPO D-SNP) | Care Improvement Plus South Central Insurance Co. | T5 | No | $0 | VA |
Showing top 50 of 98 plans.
Frequently Asked Questions
Is monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] covered by Medicare Part D?
Yes, monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] is covered by 2,152 Medicare Part D plans (42.6% of all Part D formularies).
What tier is monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] on Medicare Part D plans?
monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] averages Tier 4.2 across Part D plans, ranging from Tier 1 to Tier 5.
Does monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] require prior authorization?
95.2% of Part D formularies require prior authorization for monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]. Step therapy: 4.8%. Quantity limits: 95.2%.
How much does Medicare spend on monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam]?
In 2023, total Medicare Part D spending on monomethyl fumarate 95 MG Delayed Release Oral Capsule [Bafiertam] was $4,951,676, covering 126 beneficiaries. The average spend per beneficiary was $39,299.02.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- 0.5 ML peginterferon alfa-2a 0.36 MG/ML Prefilled Syringe [Pegasys] T4.2
- 1 ML etanercept 50 MG/ML Prefilled Syringe [Enbrel] T4.2
- 12 HR fostemsavir 600 MG Extended Release Oral Tablet [Rukobia] T4.2
- {14 (venetoclax 10 MG Oral Tablet [Venclexta]) / 21 (venetoclax 100 MG Oral Tablet [Venclexta]) / 7 (venetoclax 50 MG Oral Tablet [Venclexta]) } Pack [Venclexta Starting Pack] T4.2
- 1.5 ML elapegademase-lvlr 1.6 MG/ML Injection [Revcovi] T4.2
- {16 (tovorafenib 100 MG Oral Tablet [Ojemda]) } Pack [Ojemda 400 MG Once Weekly Carton] T4.2
Similar prior-authorization rate
- lidocaine 0.05 MG/MG Medicated Patch [Lidocan] 95.2% PA
- maralixibat 10 MG Oral Tablet [Livmarli] 95.2% PA
- abiraterone acetate 500 MG Oral Tablet 95.2% PA
- glycerol phenylbutyrate 1100 MG/ML Oral Solution 95.1% PA
- amikacin liposomal 70.3 MG/ML Inhalation Suspension [Arikayce] 95.1% PA
- lidocaine 0.05 MG/MG Medicated Patch [Tridacaine] 95% PA